The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

A University of Minnesota research team was recently awarded a five-year, $3.8 million grant from the U.S. National Institutes of Health to develop a new cell therapy to combat Alzheimer's disease.

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

A machine-learning UV absorbance spectroscopy method enables rapid, label-free detection of microbial contamination in cell ...

2025 — Scientists have developed an innovative solar-powered method to transform sewage sludge -- a by-product of wastewater treatment -- into green hydrogen for clean energy and single-cell ...

Millions of people in Cuba remain without power after a failure of the nation’s electric grid left the island in the dark.

Background GPR171 suppresses T cell immune responses involved in antitumour immunity, while its role in inflammatory bowel disease (IBD) pathogenesis remains unclear. Objective We aimed to investigate ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...

Macbecin II was identified as a compound that upregulates MHC-I expression, enhancing immune-mediated cancer cell killing. In ...

Court documents have revealed some of the text messages that the Oxford Center CEO sent about hyperbaric chambers and the ...